endometrial hyperplasia

Relationship between Endometrial Hyperplasia and Expression of Nucleus Antigen in Carcinoma of Endometrium

子宫内膜增生与内膜癌增殖细胞核抗原表达

Expression of PTEN and Ki-67 in endometrial hyperplasia and endometrial carcinoma

子宫内膜增生及内膜癌中PTEN、Ki-67蛋白的表达

Objective To study the clinical and pathological features of endometrial hyperplasia .

目的：探讨子宫内膜增殖症的临床病理学特征。

The clinical study of polycystic ovary syndrome complicated with endometrial hyperplasia

多囊卵巢综合征患者并发子宫内膜增生症的临床研究

The third was 24 cases ( 8.75 % ) with endometrial hyperplasia .

子宫内膜增殖性病变24例（8.75%）；

Classification and Diagnostic Value of Ultrasonography in Uterine Endometrial Hyperplasia

子宫内膜增生的超声分型及诊断价值

Endometrial hyperplasia in 12 cases ( 20 . 0 % ) ;

子宫内膜增殖症12例（20.0%）；

The clinical observation on the management of endometrial hyperplasia by two different dosages of mifepristone

两种剂量米非司酮治疗子宫内膜增生疗效比较

Evaluation on ISGP Classification of Endometrial Hyperplasia in Clinical Application

子宫内膜增生性病变新分类法的临床应用探讨

P53 and MDM2 Gene Expression in Endometrial Hyperplasia and Endometrial Carcinoma

MDM2、p53在增生、癌变子宫内膜的表达及其意义

Study on Expression and Correlation of Bcl-2 , ER and PR in Endometrial Hyperplasia

子宫内膜增生性病变中Bcl-2、ER、PR表达及相关性研究

Clinical Analysis of the Diagnose Accordance Rate for Atypical Endometrial Hyperplasia Pre-and Post-Operation

子宫内膜不典型增生手术前后诊断符合率临床分析

The Analysis on the Curative Effect of Highly Effective Progestogen Therapy on Atypical Endometrial Hyperplasia

高效孕激素治疗子宫内膜不典型增生的疗效分析

Clinical Study of Mifepristone and Methyltestosterone for Treating Endometrial Hyperplasia

米非司酮配伍甲基睾丸素治疗子宫内膜增生疗效分析

Endometrial hyperplasia is the main cause of abnormal uterine bleeding in perimenopausal period .

子宫内膜增生是该期异常子宫出血的主要原因。

This type of tumor can metastasize and can cause cystic endometrial hyperplasia .

该类型的肿瘤会转移并能引起囊性子宫内膜增生。

Evaluation of diagnosis of endometrial hyperplasia by curettage

子宫内膜增殖症诊断性刮宫价值的评价

Expression of Bcl-2 and PCNA oncoproteins in endometrial hyperplasia and endometrial carcinoma

BCL-2和PCNA蛋白在增生性子宫内膜和子宫内膜癌组织中的表达

Conclusion It has good curative effect to treat endometrial hyperplasia with Shaofu Zhuyu Tang .

结论少腹逐瘀汤治疗子宫内膜增殖症有较好疗效。

Down-Regulation of Ki-67 Expression by Mifepristone in Human Endometrial Hyperplasia and Adenocarcinoma in Vitro

米非司酮降调体外增生症及腺癌子宫内膜细胞Ki-67表达

Expression of Glucose Transporter-1 in Endometrial Hyperplasia and Well - Differentiated Endometrioid Adenocarcinoma

子宫内膜增生与高分化宫内膜样腺癌葡萄糖转运蛋白1型表达及其鉴别诊断意义

Study on the expression of PR , PR-B and PCNA in endometrial hyperplasia

孕酮受体、孕酮受体B亚型和增生细胞核抗原在子宫内膜增生过长组织中的表达

Endometrial Hyperplasia : A Radiologic Study

子宫内膜增生过长X线诊断的研究

Assay of estrogen and progesterone receptors in endometrial hyperplasia and adenocarcinoma of endometrium

增生过长子宫内膜和内膜腺癌雌激素、孕酮受体的检测

Objective To study the relationship between endometrial hyperplasia and the expression of proliferative cell antigen in carcinoma of endometrium and its characteristic .

目的探讨子宫内膜增生与内膜癌增殖细胞核抗原表达计数相关性，及其对判断生物学行为及预后的意义。

Comparative observation on normal endometrium , endometrial hyperplasia and endometrial adenocarcinoma with lm , sem and TEM

正常子宫内膜、内膜增生及内膜腺癌微观结构的比较研究

Shaofu Zhuyu Tang Treat Endometrial Hyperplasia 76 Cases

少腹逐瘀汤治疗子宫内膜增殖症76例

Incidences of expression of P21 protein was 72.9 % , but no expression in endometrial hyperplasia and normal endometrium .

20例子宫内膜增殖症和20例正常子宫内膜组织P21蛋白质表达阴性。

Objective To investigate the hysteroscopy ( HS ) diagnosis of endometrial hyperplasia ( EH ) of the compliance rate and influencing factors .

目的探讨宫腔镜（HS）诊断子宫内膜增生症（EH）的符合率及影响因素。

Glycosyl Located Affinity Cytochemical Study of the Adenocarcinoma of Endometrium and 3 Type of Endometrial Hyperplasia by Using Agglutinins

应用凝集素对子宫内膜增生过长和子宫内膜腺癌糖基定位亲合细胞化学研究